{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:45:50Z","timestamp":1792532750687,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11889-6","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:24:49Z","timestamp":1777541089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Insulin resistance, inflammation, oxidative stress and dysregulated WNT\/\u03b2-Catenin signaling in polycystic ovary syndrome: A review"],"prefix":"10.1007","volume":"53","author":[{"given":"Khurshid Ahmad","family":"Padder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Ashraf","family":"Ganie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmad Aadil","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasia","family":"Showkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"11889_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126403","author":"MS Rahman","year":"2021","unstructured":"Rahman MS et al (2021) Role of Insulin in health and disease: an update. Int J Mol Sci.2021, 22, 6403. https:\/\/doi.org\/10.3390\/ijms22126403","journal-title":"Int J Mol Sci"},{"issue":"10","key":"11889_CR2","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1210\/en.2003-0457","volume":"144","author":"R Burcelin","year":"2003","unstructured":"Burcelin R et al (2003) Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin. Endocrinology 144(10):4484\u20134491","journal-title":"Endocrinology"},{"issue":"4","key":"11889_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0015-0282(16)58568-9","volume":"66","author":"H Martikainen","year":"1996","unstructured":"Martikainen H et al (1996) Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil Steril 66(4):564\u2013570","journal-title":"Fertil Steril"},{"issue":"8","key":"11889_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS (2019) Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 3(8):1545\u20131573","journal-title":"J Endocr Soc"},{"key":"11889_CR5","volume-title":"Chap. 7. ectopic pregnancy Williams gynecology","author":"B Hoffman","year":"2012","unstructured":"Hoffman B et al (2012) Chap. 7. ectopic pregnancy. Williams gynecology, 2nd edn. McGraw-Hill, New York","edition":"2"},{"issue":"6865","key":"11889_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799\u2013806","journal-title":"Nature"},{"issue":"4","key":"11889_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.fertnstert.2008.10.073","volume":"93","author":"BO Pamuk","year":"2010","unstructured":"Pamuk BO et al (2010) Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters. Fertil Steril 93(4):1227\u20131233","journal-title":"Fertil Steril"},{"issue":"4","key":"11889_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/humrep\/del466","volume":"22","author":"K-M Seow","year":"2007","unstructured":"Seow K-M et al (2007) Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum Reprod 22(4):1003\u20131010","journal-title":"Hum Reprod"},{"issue":"1","key":"11889_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2008-1492","volume":"94","author":"TP Ciaraldi","year":"2009","unstructured":"Ciaraldi TP et al (2009) Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metabolism 94(1):157\u2013163","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"11889_CR10","first-page":"942","volume":"81","author":"A Dunaif","year":"1996","unstructured":"Dunaif A, Finegood DT (1996) Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metabolism 81(3):942\u2013947","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"11889_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2337\/diacare.22.2.262","volume":"22","author":"NJ Wareham","year":"1999","unstructured":"Wareham NJ et al (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22(2):262\u2013270","journal-title":"Diabetes Care"},{"issue":"1","key":"11889_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejogrb.2005.12.016","volume":"127","author":"D Panidis","year":"2006","unstructured":"Panidis D et al (2006) Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome. Eur J Obstet Gynecol Reproductive Biology 127(1):99\u2013105","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"issue":"12","key":"11889_CR13","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1210\/jc.2007-1036","volume":"92","author":"T Sir-Petermann","year":"2007","unstructured":"Sir-Petermann T et al (2007) Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metabolism 92(12):4637\u20134642","journal-title":"J Clin Endocrinol Metabolism"},{"key":"11889_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1687-9856-2012-14","volume":"2012","author":"N Raissouni","year":"2012","unstructured":"Raissouni N et al (2012) Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. Int J Pediatr Endocrinol 2012:1\u20135","journal-title":"Int J Pediatr Endocrinol"},{"issue":"10","key":"11889_CR15","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1210\/jc.2014-1474","volume":"99","author":"LC Torchen","year":"2014","unstructured":"Torchen LC et al (2014) Persistent apparent pancreatic \u03b2-cell defects in premenarchal PCOS relatives. J Clin Endocrinol Metabolism 99(10):3855\u20133862","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"7","key":"11889_CR16","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1210\/jc.2008-1664","volume":"94","author":"A Biyasheva","year":"2009","unstructured":"Biyasheva A et al (2009) Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metabolism 94(7):2617\u20132625","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"10","key":"11889_CR17","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/en.2016-1234","volume":"157","author":"M Hao","year":"2016","unstructured":"Hao M et al (2016) Overexpression of Lnk in the ovaries is involved in insulin resistance in women with polycystic ovary syndrome. Endocrinology 157(10):3709\u20133718","journal-title":"Endocrinology"},{"issue":"10","key":"11889_CR18","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2337\/diacare.22.10.1655","volume":"22","author":"JP Burke","year":"1999","unstructured":"Burke JP et al (1999) A quantitative scale of acanthosis nigricans. Diabetes Care 22(10):1655\u20131659","journal-title":"Diabetes Care"},{"issue":"1","key":"11889_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0002-9378(83)90091-1","volume":"147","author":"RL Barbieri","year":"1983","unstructured":"Barbieri RL, Ryan KJ (1983) Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 147(1):90\u2013101","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"11889_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/01.AOG.0000104485.44999.C6","volume":"103","author":"DS Guzick","year":"2004","unstructured":"Guzick DS (2004) Polycystic ovary syndrome. Obstet Gynecol 103(1):181\u2013193","journal-title":"Obstet Gynecol"},{"issue":"3","key":"11889_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0190-9622(89)70208-5","volume":"21","author":"MI Rendon","year":"1989","unstructured":"Rendon MI et al (1989) Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol 21(3):461\u2013469","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"11889_CR22","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1056\/NEJMicm1508730","volume":"374","author":"MW Lauria","year":"2016","unstructured":"Lauria MW, Saad MJ (2016) Acanthosis Nigricans and insulin resistance. N Engl J Med 374(24):e31","journal-title":"N Engl J Med"},{"key":"11889_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155142","author":"L Norton","year":"2022","unstructured":"Norton L et al (2022) Insulin: the master regulator of glucose metabolism. Metabolism.Clinical and Experimental, 2022; 129 https:\/\/doi.org\/10.1016\/j.metabol.2022.155142","journal-title":"Metabolism"},{"issue":"1","key":"11889_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1517\/14728222.2011.638626","volume":"16","author":"CE Tognon","year":"2012","unstructured":"Tognon CE, Sorensen PH (2012) Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin Ther Targets 16(1):33\u201348","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"11889_CR25","doi-asserted-by":"publisher","first-page":"e1002429","DOI":"10.1371\/journal.pgen.1002429","volume":"7","author":"W Zhang","year":"2011","unstructured":"Zhang W et al (2011) MAPK\/ERK signaling regulates insulin sensitivity to control glucose metabolism in Drosophila. PLoS Genet 7(12):e1002429","journal-title":"PLoS Genet"},{"issue":"4","key":"11889_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.4239\/wjd.v6.i4.626","volume":"6","author":"V Lambadiari","year":"2015","unstructured":"Lambadiari V, Triantafyllou K, Dimitriadis GD (2015) Insulin action in muscle and adipose tissue in type 2 diabetes: the significance of blood flow. World J Diabetes 6(4):626\u2013633","journal-title":"World J Diabetes"},{"issue":"4","key":"11889_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cmet.2021.03.020","volume":"33","author":"L Sylow","year":"2021","unstructured":"Sylow L et al (2021) The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. Cell Metabol 33(4):758\u2013780","journal-title":"Cell Metabol"},{"issue":"4","key":"11889_CR28","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98(4):2133\u20132223","journal-title":"Physiol Rev"},{"issue":"1","key":"11889_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","volume":"97","author":"AJ Duleba","year":"2012","unstructured":"Duleba AJ, Dokras AJF (2012) Is PCOS an inflammatory process? Fertil Steril 97(1):7\u201312","journal-title":"Fertil Steril"},{"issue":"8","key":"11889_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083850","volume":"22","author":"DJ Medina-Leyte","year":"2021","unstructured":"Medina-Leyte DJ et al (2021) Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. International journal of molecular sciences, 2021(8):3850","journal-title":"Int J Mol Sci"},{"key":"11889_CR31","doi-asserted-by":"publisher","unstructured":"Escobar-Morreale HF et al (2011) Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and 95(3):1048\u20131058e2 https:\/\/doi.org\/10.1016\/j.fertnstert.2010.11.036","DOI":"10.1016\/j.fertnstert.2010.11.036"},{"key":"11889_CR32","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s001250051451","volume":"42","author":"J-M Fern\u00e1ndez-Real","year":"1999","unstructured":"Fern\u00e1ndez-Real J-M, Ricart WJD (1999) Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype\/phenotype to thriftiness. Diabetologia, 42:1367\u20131374","journal-title":"Diabetologia"},{"key":"11889_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-16760-2","volume-title":"Metabolic aspects of PCOS","author":"M Stracquadanio","year":"2015","unstructured":"Stracquadanio M, Ciotta L (2015) Metabolic aspects of PCOS. Springer"},{"issue":"9","key":"11889_CR34","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1210\/jc.2005-0694","volume":"90","author":"F Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez F et al (2005) Hyperglycemia alters tumor necrosis factor-\u03b1 release from mononuclear cells in women with polycystic ovary syndrome. Journal of Clin Endocrinoland Metab 90(9):5336\u20135342","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"11889_CR35","first-page":"3789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E et al (2021) Chronic low grade Inflamm pathogenesis PCOS 22(7):3789","journal-title":"Chronic low grade Inflamm pathogenesis PCOS"},{"issue":"4","key":"11889_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","volume":"77","author":"FJS Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez FJS (2012) Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids , 77(4):300\u2013305","journal-title":"Steroids"},{"issue":"5","key":"11889_CR37","first-page":"423","volume":"32","author":"AP Cheung","year":"2010","unstructured":"Cheung AP, F.J.J.O.G C, Cog (2010) Polycystic ovary syndrome: Contemp view 32(5):423\u2013425","journal-title":"Polycystic ovary syndrome: Contemp view"},{"issue":"5","key":"11889_CR38","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM et al (2015) Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction, 149(5):R219\u2013R227","journal-title":"Reproduction"},{"issue":"1","key":"11889_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","volume":"335","author":"A Repaci","year":"2011","unstructured":"Repaci A et al (2011) The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol , 335(1):30\u201341","journal-title":"Mol Cell Endocrinol"},{"key":"11889_CR40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1556568","author":"S Shorakae","year":"2015","unstructured":"Shorakae S et al (2015) The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Semin Reprod Med.33(04): 257-269 ( Editors name:Victoria Snegovskikh ) https:\/\/doi.org\/10.1055\/s-0035-1556568","journal-title":"Semin Reprod Med"},{"key":"11889_CR41","first-page":"117955811986193","volume-title":"The possible practical implication of high CRP levels in PCOS","author":"Z Blumenfeld","year":"2019","unstructured":"Blumenfeld Z (2019) The possible practical implication of high CRP levels in PCOS. SAGE Publications Sage UK, London, England, p 1179558119861936"},{"issue":"4","key":"11889_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5152\/jtgga.2012.35","volume":"13","author":"N G\u00fcd\u00fcc\u00fc","year":"2012","unstructured":"G\u00fcd\u00fcc\u00fc N et al (2012) C-reactive protein and lipoprotein-a as markers of coronary heart disease in polycystic ovary syndrome. J Turk Ger Gynecol Assoc , 13(4):227","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"2","key":"11889_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/157340410791321336","volume":"6","author":"J Yeon Lee","year":"2010","unstructured":"Yeon Lee J et al (2010) Role of oxidative stress in polycystic ovary syndrome. Curr Womens Health Rev , 6(2):96\u2013107","journal-title":"Curr Womens Health Rev"},{"issue":"11","key":"11889_CR44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S et al (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med , 49(11):1603\u20131616","journal-title":"Free Radic Biol Med"},{"key":"11889_CR45","doi-asserted-by":"crossref","unstructured":"Tang Z et al (2022) Oxidative stress signaling mediated pathogenesis of diabetic cardiomyopathy. 2022","DOI":"10.1155\/2022\/5913374"},{"issue":"2","key":"11889_CR46","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0584","volume":"220","author":"S Guo","year":"2014","unstructured":"Guo S (2014) Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms. The Journal of Endocrinology 220(2):T1","journal-title":"J Endocrinol"},{"issue":"26","key":"11889_CR47","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.2174\/138161209789058075","volume":"15","author":"J Escobar","year":"2009","unstructured":"Escobar J et al (2009) Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: a key role for protein phosphatases. Curr Pharm Des , 15(26):3027\u20133042","journal-title":"Curr Pharm Des"},{"issue":"3","key":"11889_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.62110\/sciencein.jist.2024.v12.752","volume":"12","author":"P Sengupta","year":"2024","unstructured":"Sengupta P et al (2024) Polycystic ovary syndrome (PCOS) and oxidative stress. J Integr Sci Technol , 12(3):752\u2013752","journal-title":"J Integr Sci Technol"},{"key":"11889_CR49","doi-asserted-by":"publisher","unstructured":"Cheng X and, He (2022) Clin Biochem potential Antioxid Treat polycystic ovary syndrome :International Journal of Women's Health , Volume 14; p. 467\u2013479 https:\/\/doi.org\/10.2147\/IJWH.S345853","DOI":"10.2147\/IJWH.S345853"},{"key":"11889_CR50","first-page":"59","volume":"11","author":"SK Mehta","year":"2015","unstructured":"Mehta SK, S.J.T.J (2015) .B.p. Gowder, and c.s.o.o. stress. Members Antioxid Mach their Funct 11:59\u201385","journal-title":"Members Antioxid Mach their Funct"},{"key":"11889_CR51","doi-asserted-by":"publisher","unstructured":"Hayat R, Manzoor M (2022) J.C.b.i. Hussain, Wnt signaling pathway: A comprehensive review. Cell Biology International, 46(6):863\u2013877 https:\/\/doi.org\/10.1002\/cbin.11797","DOI":"10.1002\/cbin.11797"},{"key":"11889_CR52","first-page":"781","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, R.J.A.R.C.D B, Nusse (2004) Wnt Signal Pathw Dev disease 20:781\u2013810","journal-title":"Wnt Signal Pathw Dev disease"},{"key":"11889_CR53","doi-asserted-by":"publisher","unstructured":"Russell JO (2018) A.R.o.P.M.o.D. Monga, Wnt\/\u03b2-catenin signaling in liver development, homeostasis, and pathobiology. Annual Review of Pathology: Mechanisms of Disease ,13:351\u2013378 https:\/\/doi.org\/10.1146\/annurev-pathol-020117-044010","DOI":"10.1146\/annurev-pathol-020117-044010"},{"issue":"4","key":"11889_CR54","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/REP-14-0685","volume":"150","author":"JHJR Gifford","year":"2015","unstructured":"Gifford JHJR (2015) The role of WNT signaling in adult ovarian folliculogenesis. Reproduction , 150(4):R137\u2013R148","journal-title":"Reproduction"},{"key":"11889_CR55","doi-asserted-by":"publisher","unstructured":"Li L et al (2021) The signaling pathways involved in ovarian follicle development.Front. Physiol. 12:p730196 https:\/\/doi.org\/10.3389\/fphys.2021.730196","DOI":"10.3389\/fphys.2021.730196"},{"issue":"5","key":"11889_CR56","doi-asserted-by":"publisher","first-page":"E765","DOI":"10.1210\/jc.2011-2377","volume":"97","author":"G Chazenbalk","year":"2012","unstructured":"Chazenbalk G et al (2012) Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab , 97(5):E765\u2013E770","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"11889_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13048-025-01734-y","volume":"18","author":"KA Padder","year":"2025","unstructured":"Padder KA et al (2025) Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: outcome of a case-control study. J Ovarian Res 18(1):196","journal-title":"J Ovarian Res"},{"issue":"12","key":"11889_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084407","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu Y et al (2013) WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PLoS One , 8(12):e84407","journal-title":"PLoS One"},{"issue":"1","key":"11889_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/toxsci\/kft175","volume":"136","author":"AM Sanchez","year":"2013","unstructured":"Sanchez AM et al (2013) Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci,136(1):183\u2013192","journal-title":"Toxicol Sci"},{"issue":"1","key":"11889_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12020-024-04137-z","volume":"88","author":"KA Padder","year":"2025","unstructured":"Padder KA et al (2025) Interplay between elevated RAB5B gene expression and insulin resistance among women with PCOS-insights from a case-control study. Endocrine 88(1):323\u2013329","journal-title":"Endocrine"},{"key":"11889_CR61","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab093","author":"LM Pitzer","year":"2021","unstructured":"Pitzer LM et al (2021) WNT4 balances development vs disease in gynecologic tissues and Women\u2019s Health. Endocrinology.Volume 162, Issue 7, July 2021, bqab093, https:\/\/doi.org\/10.1210\/endocr\/bqab093","journal-title":"Endocrinology"},{"issue":"3","key":"11889_CR62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11010-023-04736-w","volume":"479","author":"W Tan","year":"2024","unstructured":"Tan W et al (2024) Insights on the NF-\u03baB system in polycystic ovary syndrome, attractive therapeutic targets. Mol Cell Biochem 479(3):467\u2013486","journal-title":"Mol Cell Biochem"},{"key":"11889_CR63","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C et al (2022) Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway. Front Endocrinol (Lausanne) 13:1091147","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11889_CR64","unstructured":"Wang Z et al (2019) Expression and Contribution of Insulin Signaling Pathway to the Development of Polycystic Ovary Syndrome, in Polycystic Ovarian Syndrome, Z. Wang, Editor. IntechOpen: London"},{"issue":"1","key":"11889_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/jc.2014-2419","volume":"100","author":"Y Zhao","year":"2015","unstructured":"Zhao Y et al (2015) Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K\/AKT\/NF-\u03baB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab 100(1):201\u2013211","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"11889_CR66","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/jc.2014-2419","volume":"100","author":"Y Zhao","year":"2015","unstructured":"Zhao Y et al (2015) Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K\/AKT\/NF-\u03baB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab , 100(1):201\u2013211","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"11889_CR67","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T et al (2017) Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome. Reprod Sci 24(5):646\u2013655","journal-title":"Reprod Sci"},{"issue":"1","key":"11889_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2108690","volume":"23","author":"CD Fleming-de-Moraes","year":"2022","unstructured":"Fleming-de-Moraes CD et al (2022) Crosstalk between PI3K\/Akt and Wnt\/\u03b2-catenin pathways promote colorectal cancer progression regardless of mutational status. Cancer Biol Ther 23(1):1\u201313","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"11889_CR69","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13048-025-01779-z","volume":"18","author":"Y Li","year":"2025","unstructured":"Li Y et al (2025) Up-regulated WNT5A in PCOS affects steroidogenesis, proliferation and apoptosis of granulosa cells through the PI3K\/AKT pathway. J Ovarian Res 18(1):262","journal-title":"J Ovarian Res"},{"issue":"6","key":"11889_CR70","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s43032-025-01832-8","volume":"32","author":"ZHA Khalil","year":"2025","unstructured":"Khalil ZHA, Altayfa O (2025) Disruption of the Wnt\/\u03b2-Catenin and PI3K-AKT-mTOR crosstalk in endometrial stromal cells: a case report of impaired decidualization leading to recurrent implantation failure and potential pathway-specific therapeutic interventions. Reprod Sci 32(6):1953\u20131958","journal-title":"Reprod Sci"},{"issue":"3","key":"11889_CR71","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.bbrc.2020.03.147","volume":"526","author":"Z Lei","year":"2020","unstructured":"Lei Z et al (2020) Activation of Wnt\/\u03b2-catenin pathway causes insulin resistance and increases lipogenesis in HepG2 cells via regulation of endoplasmic reticulum stress. Biochem Biophys Res Commun 526(3):764\u2013771","journal-title":"Biochem Biophys Res Commun"},{"key":"11889_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.730196","author":"L Li","year":"2021","unstructured":"Li L et al (2021) The signaling pathways involved in ovarian follicle development. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2021.730196","journal-title":"Front Physiol"},{"key":"11889_CR73","doi-asserted-by":"publisher","first-page":"111575","DOI":"10.1016\/j.cellsig.2024.111575","volume":"127","author":"Y Ma","year":"2025","unstructured":"Ma Y et al (2025) Wnt5a alleviates the symptoms of PCOS by modulating PI3K\/AKT\/mTOR pathway-mediated autophagy in granulosa cells. Cell Signal 127:111575","journal-title":"Cell Signal"},{"key":"11889_CR74","doi-asserted-by":"publisher","first-page":"1191759","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y (2023) Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol (Lausanne) 14:1191759","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11889-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:03:05Z","timestamp":1777575785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11889"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11889-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Statement\n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"703"}}